CORRECTED-BUZZ-U.S. Stocks on the Move-Ebola drug developers, railcar companies
(Corrects the New York Times Co item to "third quarter" from "current quarter") U.S. stocks edged lower at the open on Wednesday as caution arose following the first diagnosis of a patient in the United States with Ebola. The Dow Jones industrial average was down 0.88 percent at 16,892.35 and the S&P 500 was down 0.60 percent at 1,960.36.
** TEKMIRA PHARMACEUTICAL CORP, $25.15, +18.97 pct
** BIOCRYST PHARMACEUTICALS INC, $9.96, +1.84 pct
** SAREPTA THERAPEUTICS INC, $21.89, +3.74 pct
** NEWLINK GENETICS CORP, $23.15, +8.08 pct
** LAKELAND INDUSTRIES, $7.45, +7.19 pct
Shares of several pharmaceutical companies with potential Ebola treatments jumped after the U.S. Centers for Disease Control and Prevention confirmed on Tuesday the first case of the virus diagnosed in the country.
Shares of Lakeland Industries, which makes protective clothing for healthcare and first responders, also jumped.